Notification of eligible officers at CDTL Chennai as Govt Analyst under section 20 of the Drugs and Cosmetics Act 1940

## Policy Analysis Report: Amendment to Notification S.O. 2809(E) Regarding Drugs and Cosmetics Act, 1940 **1. Executive Summary:** This report analyzes a notification published in the Gazette of India on November 2, 2022, which amends a previous notification, S.O. 2809(E) dated November 30, 2012, related to the Drugs and Cosmetics Act, 1940. The amendment adds three new personnel to an unspecified list within the original notification: Smt. G. Sasikala (Senior Scientific Assistant), Shri Kishor Gembali (Junior Scientific Assistant), and Smt. Rimjhim Kumari (Junior Scientific Assistant). This report details the amendment's purpose, key changes, affected parties, and potential impact based solely on the provided text. **2. Introduction:** This report aims to provide an informative analysis of the amendment to notification S.O. 2809(E) concerning the Drugs and Cosmetics Act, 1940, as published in the Gazette of India on November 2, 2022. The analysis is based exclusively on the text provided, acknowledging any limitations due to the absence of the original notification or broader context. **3. Policy Overview:** * This notification is an **amendment** to the original notification S.O. 2809(E), dated November 30, 2012, published in the Gazette of India. * **Core Objective (Inferred):** The original policy appears to relate to the implementation and enforcement of the Drugs and Cosmetics Act, 1940. The amendment's objective, based on the text, is to update a roster or list of personnel involved in the administration or execution of the original policy. **4. Background and Rationale:** * **Rationale for Amendment:** The likely reason for this amendment is to update the list of personnel associated with notification S.O. 2809(E). The original notification likely involved a committee or a designated team of individuals. This amendment reflects changes in staffing or roles requiring an updated list to maintain accurate records and accountability. **5. Key Provisions / Changes:** This notification introduces the following specific changes to the original policy: * **Specific Part Being Changed:** The amendment inserts new entries *after* item number ii in the original notification. It is reasonable to infer that the original notification contains a list or roster. * **New Rule/Provision:** The *new* provision adds the following individuals, with their respective titles, to the list: * iii Smt. G. Sasikala, Senior Scientific Assistant; * iv Shri Kishor Gembali, Junior Scientific Assistant; * v Smt. Rimjhim Kumari, Junior Scientific Assistant. * **Effect of the Change:** The amendment updates the original policy's list, potentially reflecting personnel changes within the Ministry of Health and Family Welfare's Department of Health and Family Welfare. This update may be related to responsibilities for ensuring the quality, safety, and efficacy of drugs and cosmetics, based on the reference to the Drugs and Cosmetics Act, 1940. **6. Target Audience and Stakeholders:** Based on the provided text, the primary target audience and stakeholders include: * The Ministry of Health and Family Welfare, specifically the Department of Health and Family Welfare. * The individuals named in the amendment: Smt. G. Sasikala, Shri Kishor Gembali, and Smt. Rimjhim Kumari. * Potentially, other personnel within the Department of Health and Family Welfare who interact with or are affected by the roles of these individuals. * The broader pharmaceutical and cosmetics industry, as the amendment relates to the administration of the Drugs and Cosmetics Act, 1940, which governs these sectors. **7. Implementation Aspects (Inferred):** * **Responsible Agency:** The Department of Health and Family Welfare within the Ministry of Health and Family Welfare is the responsible agency. * **Timelines/Procedures:** No specific timelines or procedures are mentioned in this amendment. The amendment becomes effective upon publication in the Gazette of India. * **Amendment-Specific Aspects:** Implementation of the amendment primarily involves updating internal records and informing relevant personnel of the changes to the list. **8. Expected Outcomes / Impact of Changes:** The likely intended outcome of these specific changes is to ensure that the Department of Health and Family Welfare has an accurate and up-to-date record of relevant personnel involved in the administration of the Drugs and Cosmetics Act, 1940. The potential impact of the amendment itself is improved clarity and accountability within the department, potentially streamlining processes related to drug and cosmetic regulation. **9. Conclusion:** The amendment to notification S.O. 2809(E) updates the list of personnel associated with the Drugs and Cosmetics Act, 1940. While the provided text offers limited context regarding the original policy, the amendment appears to be a routine administrative update to maintain accurate records within the Department of Health and Family Welfare. This update is significant as it contributes to the effective implementation and enforcement of regulations governing the drugs and cosmetics industry.

Key Entities Referenced